Time to Evolve Terminology from "Debulking" to Cytoreductive Surgery (CRS) in Ovarian Cancer

Related Experiment Video

Updated: Oct 26, 2025

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.6K

Donal J Brennan1, Brendan J Moran2

  • 1UCD Gynaecological Oncology Group, Catherine McAuley Research Centre, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin 7, Ireland. donal.brennan@ucd.ie.

Annals of Surgical Oncology
|July 25, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.5K

Related Experiment Videos

Last Updated: Oct 26, 2025

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
11:29

Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma

Published on: January 22, 2022

14.6K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.5K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Tumor Progression02:07

Tumor Progression

6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K

Articles linked to this work by shared authors, journal, and citation graph.

Consistency of efficacy and safety of elinzanetant for vasomotor symptoms and sleep disturbance associated with menopause across different populations: a review of the OASIS clinical trial program.

Maturitas·2026

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy can be safely combined with nephrectomy in patients with appendiceal malignancy and synchronous renal cell carcinoma.

Journal of surgical case reports·2026

Use of magnetic resonance imaging as an adjunct to ultrasound for prenatal detection of placenta accreta spectrum.

European journal of obstetrics, gynecology, and reproductive biology·2026

Total and Tailored Mesorectal Excision for Rectal Cancer: Origins, Evolution, and Misconceptions.

Diseases of the colon and rectum·2026

Age, lifestyle, and disease affect ciliary transport in the human fallopian tube.

Scientific reports·2025

Will GLP-1 Agonists Weaken the Links between Obesity and Cancer?

Cancer discovery·2025

Society of Surgical Oncology Best Practice Statement on the Implementation of New Programs and Technologies Into Practice: An IDEAL-Informed Framework.

Annals of surgical oncology·2026

Series on the Lancet Oncology Commission on Global Cancer Surgery-Action 3: Research.

Annals of surgical oncology·2026

Flexible Large Language Models for Multi-variable Extraction in Sarcoma Pathology Notes: A Pilot Study.

Annals of surgical oncology·2026

Extent of Lymph Node Examination in Older Adults with Gastric Adenocarcinoma: Is There a Trade-off Between Survival and Short-Term Outcomes? : Benefit of Lymph Node Yield in Older Adults with Gastric Cancer.

Annals of surgical oncology·2026

Primum Non Nocere: Ethical Considerations of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) in Peritoneal Malignancies.

Annals of surgical oncology·2026

Prognostic Impact of the Combined Use of CA19-9 and DUPAN-2 in Initially Unresectable Locally Advanced Pancreatic Adenocarcinoma.

Annals of surgical oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us